William Blair Initiates Coverage On Revolution Medicines with Outperform Rating

William Blair analyst Alethia Young has initiated coverage on Revolution Medicines (NASDAQ: RVMD) with an Outperform rating. This marks a positive outlook for the company as it enters a new phase of market analysis.